bibliographic entry 12498226 [be/12498226]
https://w3id.org/oc/corpus/be/12498226

is a

• bibliographic reference

content

• Navid, F, Sondel, PM, Barfield, R, Shulkin, BL, Kaufman, RA, Allay, JA. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol (2014) 32: 1445–52. DOI: 10.1200/JCO.2013.50.4423 PMID: 24711551

references

• https://w3id.org/oc/corpus/br/3268820